Pfizer Excludes Asian and White Applicants from Fellowship Program
September 3, 2022
Pfizer recently launched a “Breakthrough Fellowship Program,” which aims to enroll 100 fellows within three years. The 9-year commitment aims to fully fund a master’s degree as well as allow fellows to get summer internships, two years of employment after undergraduate graduation, and a return to Pfizer after graduate studies.
There’s just one problem, only Black/African-American, Latino/Hispanic, and Native-Americans qualify. Asian-American and Anglo-Americans—who dominate the field of medicine—are not included in Pfizer’s list.
Asian-Americans are about 6.1% of the U.S. population but make up about 17.1% of physicians. Anglo-Americans are 59.3% of the U.S. population and make up about 56.2% of physicians. Latino/Hispanic population is 18.7% and accounts for 5.8% of physicians while Black/African-Americans are 13.4% of the U.S. population and account for 5% of physicians, according to AAMC.
Pfizer is currently looking for the next generation of Black and Latino leaders with at least a 3.0 GPA.
“One of Pfizer’s Bold Moves is to create a workplace for all, and we are committed to increasing diversity by fostering a more inclusive workplace,” the company wrote.
“We have every confidence that all of our actions comply fully with all U.S. employment laws, including the Breakthrough Fellowship Program,” a spokesperson for Pfizer told FOX Business. “At Pfizer, we create opportunities for people without taking them away from others. We will continue to strive to create more opportunity, including through specific programs designed to cast a wide net for talent.”
However, many analysts say Pfizer’s racial requirements are against federal law.
Gail Heriot, a University of San Diego law professor and member of the U.S Commission on Civil Rights, told the Washington Free Beacon: “Major corporations seem to have forgotten that there’s such a thing as law. They seem to think that as long as they’re woke, they’re bulletproof.”